Literature DB >> 15728068

Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies.

Rudolf Likar1, Reinhard Sittl.   

Abstract

The use of opioids for treating neuropathic pain is controversial, and some studies have indicated that neuropathic pain may be relatively insensitive to typical mu-opioid analgesics such as morphine. However, it is becoming clear that different opioids produce analgesia by affecting different pain pathways. We present two cases of neuropathic pain and two cases of nociceptive pain with a significant neuropathic component that were treated with transdermal buprenorphine. In each case, sufficient pain relief was obtained and no problems were encountered in switching from prior analgesic therapy with larger doses of other opioids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728068     DOI: 10.1213/01.ANE.0000145066.06538.20

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  10 in total

Review 1.  Transdermal treatment options for neurological disorders: impact on the elderly.

Authors:  Lorenzo Priano; Maria Rosa Gasco; Alessandro Mauro
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 2.  Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management.

Authors:  Paul J Christo; Greg Hobelmann; David N Maine
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 3.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 4.  Pediatric palliative care: use of opioids for the management of pain.

Authors:  Boris Zernikow; Erik Michel; Finella Craig; Brian J Anderson
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

5.  Transdermal buprenorphine - a critical appraisal of its role in pain management.

Authors:  Guy Hans; Dominique Robert
Journal:  J Pain Res       Date:  2009-09-15       Impact factor: 3.133

Review 6.  Management of chronic pain in the elderly: focus on transdermal buprenorphine.

Authors:  Nalini Vadivelu; Roberta L Hines
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

7.  Transdermal buprenorphine in the management of persistent pain - safety aspects.

Authors:  Rudolf Likar
Journal:  Ther Clin Risk Manag       Date:  2006-03       Impact factor: 2.423

8.  Stem cell therapy for neuropathic pain treatment.

Authors:  D Siniscalco; F Rossi; S Maione
Journal:  J Stem Cells Regen Med       Date:  2007-11-14

Review 9.  Buprenorphine - an attractive opioid with underutilized potential in treatment of chronic pain.

Authors:  Ish K Khanna; Sivaram Pillarisetti
Journal:  J Pain Res       Date:  2015-12-04       Impact factor: 3.133

10.  A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.

Authors:  Krzysztof Nosek; Wojciech Leppert; Hanna Nosek; Jerzy Wordliczek; Dariusz Onichimowski
Journal:  Drug Des Devel Ther       Date:  2017-08-22       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.